Antiretroviral treatment and prevention of mother-to-child transmission of human immunodeficiency virus in women with acquired immunodeficiency syndrome

CAI Ren-Tian1; LU Hong-Zhou1; 2; 3

PDF(560 KB)

Journal of Microbes and Infections ›› 2014, Vol. 9 ›› Issue (3) : 191-196.

Summary

Antiretroviral treatment and prevention of mother-to-child transmission of human immunodeficiency virus in women with acquired immunodeficiency syndrome

CAI Ren-Tian¹，LU Hong-Zhou^1,2,3

Author information +

History +

Abstract

Since antiretroviral therapy was implemented in pregnant women infected with human immunodeficiency virus (HIV), the success rate of prevention of mother-to-child transmission (PMTCT) of HIV has been increased significantly. And some antiviral drugs, such as efavirenz and tenofovir, have gradually been proven to be safe for pregnant women and fetus. The range of options for PMTCT drugs is increased.

Key words

Acquired immunodeficiency syndrome / Human immunodeficiency virus / Antiretroviral / Prevention of mother-to-child transmission

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

CAI Ren-Tian1，LU Hong-Zhou1,2,3. Antiretroviral treatment and prevention of mother-to-child transmission of human immunodeficiency virus in women with acquired immunodeficiency syndrome[J]. Journal of Microbes and Infections. 2014, 9(3): 191-196